H.C Wainright Downgrades Cesca Therapeutics To Neutral

H.C Wainright downgraded

from Buy to Neutral. Cesca Therapeutics shares have dropped 48.10 percent over the past 52 weeks, while the S&P 500 index has surged 12.95 percent in the same period. Cesca Therapeutics' shares closed at $0.820 yesterday.